Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins-Reference-Cited by-同舟云学术

Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins

Published:2011-02-14 Issue:1 Volume:19 Page:109-117
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:Eur J Prev Cardiolog

Author:

Krobot Karl J¹²,Wagner Alexander¹,Siebert Uwe²

Affiliation:

1. MSD Sharp & Dohme, Lindenplatz 1, 85540 Haar, Germany.

2. Department of Public Health, Information Systems and Health Technology Assessment, UMIT – University for Health Sciences, Medical Informatics and Technology, Hall i T, Austria.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1741826710392668

Reference13 articles.

1. Evidence-based goals versus achievement in clinical practice in secondary prevention of coronary heart disease: findings in EUROASPIRE II

2. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

4. Creating and Synthesizing Evidence With Decision Makers in Mind

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do acute coronary events affect lipid management and cholesterol goal attainment in Germany?;Wiener klinische Wochenschrift;2018-09-03

2. Ezetimibe/statin combination therapy to treat patients with type 2 diabetes;Atherosclerosis Supplements;2015-02

3. A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI);Diabetes Technology & Therapeutics;2014-02

4. Gas chromatography analysis of serum cholesterol synthesis and absorption markers used to predict the efficacy of simvastatin in patients with coronary heart disease;Clinical Biochemistry;2013-08

5. Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2013-01